Asian stock market: On the bids despite downbeat China PMI, trade war hints

MSCI’s Asia-Pacific Index surges to the six-week top amid promising cure to the pandemic.
Chinese PMIs soften in April, US President Trump raised doubts on the US-China trade deal.
US GDP, Fed failed to defy Wall Street’s rally on virus treatment hopes.
US Jobless Claims, ECB and news concerning the COVID-19 will be in focus.

Asian traders followed the footsteps of Wall Street, buoyed by the hopes of a cure to the coronavirus (COVID-19) while heading into the European session on Thursday.

In doing so, Asian markets ignored the downbeat performance of China’s April month PMIs, be it official or Caixin, while also paying a little heed to fresh US-China trade war hints by US President Donald Trump.

While portraying the mood, MSCI’s Asia-Pacific index outside Japan surges to the highest since mid-March, up 1.1% now, whereas Japan’s NIKKEI gains 2.70% to 20,315 despite mixed Retail Trade and Industrial Production data.

Further, Chinese equities remain on the front foot with over 1.0% gains by the time of writing whereas those from India seem to benefit from the government’s signals to ease lockdown during early May.

Additionally, shares in Australia benefited from the virus hopes but New Zealand’s NZX 50 drops 1.0% by the time of writing. Furthermore, Indonesia’s IDX Composite and South Korea’s KOSPI were also decorating the gain series while being around 2.60% and 0.70% in green by the press time.

It’s worth mentioning that Wall Street paid a little heed to the US GDP contraction and Fed’s dovish halt during the previous day. Even so, the US 10-year Treasury yields drop 1.3 basis points (bps) to 0.614% as we write.

It’s ECB day for the markets and hence nothing will be paid more attention, except for the US Jobless Claims that are in fashion off-late. While the European Central Bank (ECB) isn’t expected to alter the current monetary policy, the President’s press conference will be the key to watch. Moving on, US Jobless Claims are expected to recover from 4,427K to 3,500K.

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.